| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.91e-08 | 46 | 215 | 8 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | EMILIN2 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 LAMC2 MEGF9 ELN AGRN | 1.34e-07 | 188 | 215 | 13 | GO:0005201 |
| GeneOntologyMolecularFunction | ethanol binding | 1.93e-07 | 6 | 215 | 4 | GO:0035276 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 4.97e-06 | 24 | 215 | 5 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 7.56e-06 | 26 | 215 | 5 | GO:0004022 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 9.72e-06 | 127 | 215 | 9 | GO:0016616 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.58e-05 | 30 | 215 | 5 | GO:0018455 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 1.90e-05 | 138 | 215 | 9 | GO:0016614 | |
| GeneOntologyMolecularFunction | actinin binding | 9.53e-05 | 43 | 215 | 5 | GO:0042805 | |
| GeneOntologyMolecularFunction | NAD binding | 1.36e-04 | 73 | 215 | 6 | GO:0051287 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 3.27e-04 | 31 | 215 | 4 | GO:0051393 | |
| GeneOntologyMolecularFunction | isocitrate dehydrogenase (NAD+) activity | 3.44e-04 | 3 | 215 | 2 | GO:0004449 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 4.10e-04 | 14 | 215 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX2 SP4 ZBTB48 MAZ PDX1 ETV3 SOX8 HMX1 STAT6 KAT2B SALL2 FOXD4L1 ZNF852 PURA BHLHE22 FOXE1 FOXD2 TCF7 RARA RARG NACC1 MED8 RELB ZBTB7B RFX5 PREB ARNT ZNF853 PBX3 SP7 | 4.74e-04 | 1459 | 215 | 30 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX2 SP4 ZBTB48 MAZ PDX1 SOX8 STAT6 SALL2 FOXD4L1 ZNF852 BHLHE22 FOXE1 FOXD2 TCF7 RARA RARG NACC1 MED8 RELB ZBTB7B RFX5 PREB ARNT ZNF853 PBX3 SP7 | 9.15e-04 | 1244 | 215 | 26 | GO:0000978 |
| GeneOntologyMolecularFunction | isocitrate dehydrogenase [NAD(P)+] activity | 1.13e-03 | 5 | 215 | 2 | GO:0004448 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX2 SP4 ZBTB48 MAZ PDX1 SOX8 STAT6 SALL2 FOXD4L1 ZNF852 BHLHE22 FOXE1 FOXD2 TCF7 RARA RARG NACC1 MED8 RELB ZBTB7B RFX5 PREB ARNT ZNF853 PBX3 SP7 | 1.24e-03 | 1271 | 215 | 26 | GO:0000987 |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 1.12e-06 | 3 | 215 | 3 | GO:0046186 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 1.10e-05 | 5 | 215 | 3 | GO:0006117 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 3.13e-05 | 18 | 215 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ABL1 ITGB3 COL24A1 ZNF469 RECK COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 IER3IP1 ELN | 4.45e-05 | 377 | 215 | 14 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ABL1 ITGB3 COL24A1 ZNF469 RECK COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 IER3IP1 ELN | 4.57e-05 | 378 | 215 | 14 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ABL1 ITGB3 COL24A1 ZNF469 RECK COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 IER3IP1 ELN | 4.71e-05 | 379 | 215 | 14 | GO:0045229 |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 6.16e-05 | 95 | 215 | 7 | GO:0006081 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 1.14e-04 | 73 | 215 | 6 | GO:1901616 | |
| GeneOntologyCellularComponent | collagen trimer | COL26A1 EMILIN2 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 | 2.52e-08 | 88 | 216 | 10 | GO:0005581 |
| GeneOntologyCellularComponent | collagen type IX trimer | 4.32e-06 | 4 | 216 | 3 | GO:0005594 | |
| GeneOntologyCellularComponent | I band | 9.21e-06 | 166 | 216 | 10 | GO:0031674 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 2.13e-05 | 6 | 216 | 3 | GO:0005593 | |
| GeneOntologyCellularComponent | Z disc | 2.82e-05 | 151 | 216 | 9 | GO:0030018 | |
| GeneOntologyCellularComponent | myofibril | PDLIM7 KAT2B KCNA5 MYOZ1 AHNAK SCN8A MYO18B FLNA FLNB FLNC TRIM32 SMN1 | 2.88e-05 | 273 | 216 | 12 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | PDLIM7 KAT2B KCNA5 MYOZ1 AHNAK SCN8A MYO18B FLNA FLNB FLNC TRIM32 SMN1 | 5.18e-05 | 290 | 216 | 12 | GO:0043292 |
| GeneOntologyCellularComponent | complex of collagen trimers | 5.78e-05 | 21 | 216 | 4 | GO:0098644 | |
| GeneOntologyCellularComponent | sarcomere | PDLIM7 KAT2B KCNA5 MYOZ1 SCN8A MYO18B FLNA FLNB FLNC TRIM32 SMN1 | 5.94e-05 | 249 | 216 | 11 | GO:0030017 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL26A1 EMILIN2 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 LAMC2 MEGF9 CLEC14A ELN SNORC AGRN | 1.34e-04 | 530 | 216 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | alphav-beta3 integrin-vitronectin complex | 3.17e-04 | 3 | 216 | 2 | GO:0071062 | |
| GeneOntologyCellularComponent | isocitrate dehydrogenase complex (NAD+) | 3.17e-04 | 3 | 216 | 2 | GO:0045242 | |
| GeneOntologyCellularComponent | extracellular matrix | LRRC3C COL26A1 EMILIN2 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 LAMC2 MEGF9 CLEC14A ELN SNORC AGRN | 4.93e-04 | 656 | 216 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LRRC3C COL26A1 EMILIN2 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 LAMC2 MEGF9 CLEC14A ELN SNORC AGRN | 5.11e-04 | 658 | 216 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | supramolecular polymer | PDLIM7 KAT2B KCNA5 MID1IP1 MYOZ1 AHNAK SCN8A MYO18B DNAH9 COL1A2 COL4A2 COL4A6 FLNA FLNB FLNC COL11A2 IFFO1 DNM1L SLC8A2 TRIM32 SMN1 ELN CTPS1 UPP2 | 1.31e-03 | 1187 | 216 | 24 | GO:0099081 |
| GeneOntologyCellularComponent | ruffle | 1.40e-03 | 206 | 216 | 8 | GO:0001726 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.55e-03 | 6 | 216 | 2 | GO:0005587 | |
| Domain | ADH_Zn_CS | 1.10e-08 | 8 | 217 | 5 | IPR002328 | |
| Domain | ADH_ZINC | 1.10e-08 | 8 | 217 | 5 | PS00059 | |
| Domain | Collagen | COL26A1 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 | 6.26e-07 | 85 | 217 | 9 | IPR008160 |
| Domain | Collagen | COL26A1 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 | 6.26e-07 | 85 | 217 | 9 | PF01391 |
| Domain | PKS_ER | 7.96e-07 | 16 | 217 | 5 | IPR020843 | |
| Domain | ADH_N | 7.96e-07 | 16 | 217 | 5 | PF08240 | |
| Domain | PKS_ER | 7.96e-07 | 16 | 217 | 5 | SM00829 | |
| Domain | ADH_N | 7.96e-07 | 16 | 217 | 5 | IPR013154 | |
| Domain | - | 1.53e-06 | 18 | 217 | 5 | 3.90.180.10 | |
| Domain | ADH_zinc_N | 2.06e-06 | 19 | 217 | 5 | PF00107 | |
| Domain | ADH_SF_Zn-type | 2.06e-06 | 19 | 217 | 5 | IPR002085 | |
| Domain | ADH_C | 2.06e-06 | 19 | 217 | 5 | IPR013149 | |
| Domain | GroES-like | 7.18e-06 | 24 | 217 | 5 | IPR011032 | |
| Domain | Laminin_G | 5.61e-05 | 58 | 217 | 6 | IPR001791 | |
| Domain | TSPN | 1.32e-04 | 23 | 217 | 4 | SM00210 | |
| Domain | IG_FLMN | 1.75e-04 | 10 | 217 | 3 | SM00557 | |
| Domain | EMI | 1.75e-04 | 10 | 217 | 3 | PF07546 | |
| Domain | Filamin | 2.38e-04 | 11 | 217 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 2.38e-04 | 11 | 217 | 3 | PS50194 | |
| Domain | NC1_FIB | 2.38e-04 | 11 | 217 | 3 | PS51461 | |
| Domain | Filamin/ABP280_rpt | 2.38e-04 | 11 | 217 | 3 | IPR001298 | |
| Domain | Fib_collagen_C | 2.38e-04 | 11 | 217 | 3 | PD002078 | |
| Domain | Filamin/ABP280_repeat-like | 2.38e-04 | 11 | 217 | 3 | IPR017868 | |
| Domain | Fib_collagen_C | 2.38e-04 | 11 | 217 | 3 | IPR000885 | |
| Domain | COLFI | 2.38e-04 | 11 | 217 | 3 | PF01410 | |
| Domain | COLFI | 2.38e-04 | 11 | 217 | 3 | SM00038 | |
| Domain | PDZ | 2.46e-04 | 141 | 217 | 8 | PF00595 | |
| Domain | EGF-like_CS | PGAP6 ITGB3 UMODL1 LAMC2 CUBN CELSR2 MEGF9 CLEC14A EPHA2 CSPG5 AGRN | 2.49e-04 | 261 | 217 | 11 | IPR013032 |
| Domain | EGF_2 | PGAP6 ITGB3 UMODL1 LAMC2 CUBN CELSR2 MEGF9 CLEC14A EPHA2 CSPG5 AGRN | 2.83e-04 | 265 | 217 | 11 | PS01186 |
| Domain | PDZ | 3.42e-04 | 148 | 217 | 8 | SM00228 | |
| Domain | - | 3.74e-04 | 150 | 217 | 8 | 2.30.42.10 | |
| Domain | EGF_LAM_2 | 3.83e-04 | 30 | 217 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 3.83e-04 | 30 | 217 | 4 | PS01248 | |
| Domain | PDZ | 3.91e-04 | 151 | 217 | 8 | PS50106 | |
| Domain | Isocitrate_DH_NAD | 4.00e-04 | 3 | 217 | 2 | IPR004434 | |
| Domain | PDZ | 4.09e-04 | 152 | 217 | 8 | IPR001478 | |
| Domain | EGF | PGAP6 GPR179 UMODL1 LAMC2 CUBN CELSR2 MEGF9 CLEC14A CSPG5 AGRN | 4.40e-04 | 235 | 217 | 10 | SM00181 |
| Domain | EGF_Lam | 7.00e-04 | 35 | 217 | 4 | SM00180 | |
| Domain | Laminin_EGF | 7.00e-04 | 35 | 217 | 4 | PF00053 | |
| Domain | EMI_domain | 7.75e-04 | 16 | 217 | 3 | IPR011489 | |
| Domain | Retinoic_acid_rcpt | 7.94e-04 | 4 | 217 | 2 | IPR003078 | |
| Domain | EGF_1 | PGAP6 ITGB3 UMODL1 LAMC2 CUBN CELSR2 MEGF9 CLEC14A CSPG5 AGRN | 8.27e-04 | 255 | 217 | 10 | PS00022 |
| Domain | - | 8.45e-04 | 95 | 217 | 6 | 2.60.120.200 | |
| Domain | EMI | 9.33e-04 | 17 | 217 | 3 | PS51041 | |
| Domain | Laminin_EGF | 9.60e-04 | 38 | 217 | 4 | IPR002049 | |
| Domain | BTB | 1.24e-03 | 180 | 217 | 8 | SM00225 | |
| Domain | Isocitrate/isopropylmalate_DH | 1.31e-03 | 5 | 217 | 2 | IPR001804 | |
| Domain | Iso_dh | 1.31e-03 | 5 | 217 | 2 | PF00180 | |
| Domain | IsoCit/isopropylmalate_DH_CS | 1.31e-03 | 5 | 217 | 2 | IPR019818 | |
| Domain | Iso_dh | 1.31e-03 | 5 | 217 | 2 | SM01329 | |
| Domain | IDH_IMDH | 1.31e-03 | 5 | 217 | 2 | PS00470 | |
| Domain | IsoPropMal-DH-like_dom | 1.31e-03 | 5 | 217 | 2 | IPR024084 | |
| Domain | - | 1.31e-03 | 5 | 217 | 2 | 3.40.718.10 | |
| Domain | BTB/POZ_dom | 1.47e-03 | 185 | 217 | 8 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 1.68e-03 | 189 | 217 | 8 | IPR011333 | |
| Domain | C4 | 1.95e-03 | 6 | 217 | 2 | SM00111 | |
| Domain | Collagen_VI_NC | 1.95e-03 | 6 | 217 | 2 | IPR001442 | |
| Domain | NC1_IV | 1.95e-03 | 6 | 217 | 2 | PS51403 | |
| Domain | - | 1.95e-03 | 6 | 217 | 2 | 2.170.240.10 | |
| Domain | C4 | 1.95e-03 | 6 | 217 | 2 | PF01413 | |
| Domain | SEA | 2.02e-03 | 22 | 217 | 3 | PF01390 | |
| Domain | ACTININ_2 | 2.31e-03 | 23 | 217 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.31e-03 | 23 | 217 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.31e-03 | 23 | 217 | 3 | IPR001589 | |
| Domain | SEA | 2.31e-03 | 23 | 217 | 3 | PS50024 | |
| Domain | SEA_dom | 2.31e-03 | 23 | 217 | 3 | IPR000082 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL26A1 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 | 1.13e-09 | 44 | 158 | 9 | M27812 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.46e-08 | 41 | 158 | 8 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL26A1 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 | 5.45e-08 | 67 | 158 | 9 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL26A1 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 LAMC2 | 6.23e-08 | 90 | 158 | 10 | M631 |
| Pathway | REACTOME_ETHANOL_OXIDATION | 1.23e-07 | 12 | 158 | 5 | M14663 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.71e-07 | 61 | 158 | 8 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.71e-07 | 61 | 158 | 8 | MM14637 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.42e-07 | 85 | 158 | 9 | M16441 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 4.55e-07 | 15 | 158 | 5 | M39717 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 5.42e-07 | 64 | 158 | 8 | M26953 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL26A1 EMILIN2 ITGA5 ITGB3 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 LAMC2 ELN AGRN | 1.40e-06 | 300 | 158 | 15 | M610 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.06e-06 | 76 | 158 | 8 | MM14867 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.06e-06 | 76 | 158 | 8 | MM14573 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 3.03e-06 | 10 | 158 | 4 | MM15833 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL26A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 LAMC2 ELN | 3.87e-06 | 140 | 158 | 10 | M587 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.07e-06 | 59 | 158 | 7 | M27218 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.42e-06 | 84 | 158 | 8 | M7098 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 4.72e-06 | 11 | 158 | 4 | MM15405 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL26A1 EMILIN2 ITGA5 ITGB3 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 ELN AGRN | 6.70e-06 | 258 | 158 | 13 | MM14572 |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 6.77e-06 | 42 | 158 | 6 | M699 | |
| Pathway | WP_RETINOL_METABOLISM | 8.95e-06 | 44 | 158 | 6 | MM15851 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.17e-05 | 46 | 158 | 6 | M198 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.69e-05 | 49 | 158 | 6 | MM15186 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.87e-05 | 74 | 158 | 7 | M160 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.88e-05 | 15 | 158 | 4 | M27161 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.91e-05 | 50 | 158 | 6 | MM14796 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.22e-05 | 76 | 158 | 7 | M27219 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.62e-05 | 32 | 158 | 5 | MM14924 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 6.60e-05 | 62 | 158 | 6 | M11521 | |
| Pathway | REACTOME_ABACAVIR_ADME | 7.42e-05 | 8 | 158 | 3 | MM14869 | |
| Pathway | KEGG_FOCAL_ADHESION | ITGA5 ITGB3 COL1A2 COL4A2 COL4A6 FLNA FLNB FLNC COL11A2 LAMC2 | 8.19e-05 | 199 | 158 | 10 | M7253 |
| Pathway | KEGG_TYROSINE_METABOLISM | 1.01e-04 | 42 | 158 | 5 | M16743 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.01e-04 | 42 | 158 | 5 | M7169 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.13e-04 | 43 | 158 | 5 | M27443 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.74e-04 | 47 | 158 | 5 | MM14925 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 2.13e-04 | 11 | 158 | 3 | M48099 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 2.52e-04 | 28 | 158 | 4 | MM15188 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.09e-04 | 53 | 158 | 5 | MM14566 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.32e-04 | 30 | 158 | 4 | M27772 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 3.78e-04 | 31 | 158 | 4 | M39714 | |
| Pathway | WP_FOCAL_ADHESION | 4.08e-04 | 199 | 158 | 9 | M39402 | |
| Pathway | WP_PI3KAKT_SIGNALING | MCL1 ITGA5 ITGB3 PHLPP1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 LAMC2 EPHA2 IL4R | 4.39e-04 | 339 | 158 | 12 | M39736 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.91e-04 | 63 | 158 | 5 | M11187 | |
| Pathway | KEGG_RETINOL_METABOLISM | 7.43e-04 | 64 | 158 | 5 | M9488 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 8.55e-04 | 66 | 158 | 5 | M18 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 9.21e-04 | 39 | 158 | 4 | MM14601 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 9.96e-04 | 18 | 158 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 9.96e-04 | 18 | 158 | 3 | MM14882 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.11e-03 | 104 | 158 | 6 | M738 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.11e-03 | 41 | 158 | 4 | M27778 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.12e-03 | 70 | 158 | 5 | M16794 | |
| Pathway | WP_FOCAL_ADHESION | 1.22e-03 | 187 | 158 | 8 | MM15913 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.27e-03 | 72 | 158 | 5 | M9257 | |
| Pathway | WP_VITAMIN_A_AND_CAROTENOID_METABOLISM | 1.33e-03 | 43 | 158 | 4 | M39554 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.37e-03 | 20 | 158 | 3 | MM15061 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.45e-03 | 44 | 158 | 4 | M26969 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.78e-03 | 114 | 158 | 6 | MM14571 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 1.82e-03 | 6 | 158 | 2 | M48097 | |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 1.82e-03 | 6 | 158 | 2 | MM1447 | |
| Pathway | WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES | 1.82e-03 | 6 | 158 | 2 | M39872 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.82e-03 | 22 | 158 | 3 | M27445 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | ITGA5 ITGB3 PHLPP1 COL1A2 COL4A2 COL4A6 COL11A2 LAMC2 EPHA2 IL4R | 2.16e-03 | 302 | 158 | 10 | M39719 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 TBC1D9B ABL1 KMT2B ITGA5 SRCAP SAP30 MPRIP PCNX2 EHBP1L1 AHNAK TMEM132A EXOSC6 SCN8A KBTBD11 SLC52A2 FLNA FLNC RARG RELB NUBPL CCDC142 CELSR2 CDK13 NEK8 CABIN1 AGRN IL4R ARHGAP33 TJP3 | 1.94e-11 | 1105 | 219 | 30 | 35748872 |
| Pubmed | SOX2 IRF2BP2 KMT2B MAZ ETV3 POGZ SRCAP MPRIP LONP1 KAT2B SALL2 MID1IP1 PPIL3 PURA PIP4P1 TCF7 NACC1 MED8 PPIL4 COP1 RELB RFX5 PPM1G MED15 ARNT HNRNPUL2 SLC25A10 AUTS2 SMN1 CABIN1 PCDH7 SLX4 EXOC4 SP7 | 2.75e-11 | 1429 | 219 | 34 | 35140242 | |
| Pubmed | Merging protein, gene and genomic data: the evolution of the MDR-ADH family. | 5.65e-11 | 6 | 219 | 5 | 16121213 | |
| Pubmed | Human liver alcohol dehydrogenase: purification, composition, and catalytic features. | 5.65e-11 | 6 | 219 | 5 | 9982 | |
| Pubmed | 1.97e-10 | 7 | 219 | 5 | 11784316 | ||
| Pubmed | 1.97e-10 | 7 | 219 | 5 | 23456092 | ||
| Pubmed | Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism. | 1.97e-10 | 7 | 219 | 5 | 23468174 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX2 SP4 ZBTB48 MAZ PDX1 ETV3 SOX8 HMX1 STAT6 SALL2 FOXD4L1 BHLHE22 FOXE1 FOXD2 TCF7 RARA RARG RELB BOLA1 ZNF385A ZBTB7B RFX5 ARNT PBX3 SP7 | 7.93e-10 | 908 | 219 | 25 | 19274049 |
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 12631290 | ||
| Pubmed | 3.99e-09 | 22 | 219 | 6 | 10753524 | ||
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 11836246 | ||
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 1316195 | ||
| Pubmed | ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. | 7.61e-09 | 5 | 219 | 4 | 19193628 | |
| Pubmed | Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. | 7.61e-09 | 5 | 219 | 4 | 22079585 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | EMILIN2 COL24A1 COL1A2 COL4A2 COL4A6 COL11A2 COL16A1 LAMC2 ELN AGRN | 1.58e-08 | 135 | 219 | 10 | 28675934 |
| Pubmed | Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. | 2.27e-08 | 6 | 219 | 4 | 17185388 | |
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 17257171 | ||
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 12027900 | ||
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 518534 | ||
| Pubmed | 2.83e-08 | 50 | 219 | 7 | 23658023 | ||
| Pubmed | 4.60e-08 | 32 | 219 | 6 | 17270348 | ||
| Pubmed | EMILIN2 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL16A1 LAMC2 ELN | 5.23e-08 | 153 | 219 | 10 | 25037231 | |
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 16047160 | ||
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 16076904 | ||
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 16685648 | ||
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 18331377 | ||
| Pubmed | EMILIN2 COL24A1 COL1A2 COL4A2 COL4A6 COL16A1 LAMC2 CLEC14A ELN AGRN | 1.19e-07 | 167 | 219 | 10 | 22159717 | |
| Pubmed | 1.88e-07 | 9 | 219 | 4 | 11807098 | ||
| Pubmed | 1.88e-07 | 9 | 219 | 4 | 11747070 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 2737681 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 2.46e-07 | 3 | 219 | 3 | 24787690 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 3011597 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 7840644 | ||
| Pubmed | Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. | 2.46e-07 | 3 | 219 | 3 | 15670660 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 12393796 | ||
| Pubmed | Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase. | 2.46e-07 | 3 | 219 | 3 | 3157987 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 2169444 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 11153914 | ||
| Pubmed | Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. | 2.46e-07 | 3 | 219 | 3 | 9145544 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 3428612 | ||
| Pubmed | Genetic and developmental regulation of mouse liver alcohol dehydrogenase. | 2.46e-07 | 3 | 219 | 3 | 6816803 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 35354963 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 11960985 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 2474823 | ||
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 2.46e-07 | 3 | 219 | 3 | 23772048 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 8163197 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 6756216 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 37806378 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 8018987 | ||
| Pubmed | Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1. | 2.46e-07 | 3 | 219 | 3 | 33586683 | |
| Pubmed | A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1. | 2.46e-07 | 3 | 219 | 3 | 8486690 | |
| Pubmed | Individual susceptibility and alcohol effects:biochemical and genetic aspects. | 2.46e-07 | 3 | 219 | 3 | 16801720 | |
| Pubmed | Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. | 2.46e-07 | 3 | 219 | 3 | 10424757 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 11252955 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 2347582 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 17326332 | ||
| Pubmed | The role of alcohol dehydrogenase in retinoic acid homeostasis and fetal alcohol syndrome. | 2.46e-07 | 3 | 219 | 3 | 7748347 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 3006456 | ||
| Pubmed | Alcohol dehydrogenase polymorphisms influence alcohol-elimination rates in a male Jewish population. | 2.46e-07 | 3 | 219 | 3 | 14745297 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 8973327 | ||
| Pubmed | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 2.46e-07 | 3 | 219 | 3 | 15554233 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 6370228 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 2935875 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | IRF2BP2 ATP6V1A CDSN MPRIP SHKBP1 AHNAK ASPSCR1 FLNA FLNB FLNC UBQLN2 PPFIA3 TRIM32 KCTD3 CTPS1 | 4.29e-07 | 477 | 219 | 15 | 31300519 |
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 1693626 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 8813054 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 9733106 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 9202249 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 19618839 | ||
| Pubmed | Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties. | 9.81e-07 | 4 | 219 | 3 | 3996732 | |
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 9241435 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 15193143 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 19687126 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 11739414 | ||
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 9.81e-07 | 4 | 219 | 3 | 22802962 | |
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 2893758 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 11893554 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 29663519 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 12851412 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 36224745 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 10880953 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 9002638 | ||
| Pubmed | ITGB3 ADH1A ADH1B ADH1C ADH4 SALL2 FOXE1 FLNB COL11A2 RARA RARG ARNT | 1.46e-06 | 331 | 219 | 12 | 20634891 | |
| Pubmed | COL24A1 COL1A2 COL4A2 COL4A6 COL9A2 COL11A2 COL16A1 ELN AGRN | 1.84e-06 | 175 | 219 | 9 | 28071719 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 1.98e-06 | 15 | 219 | 4 | 9832566 | |
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 19861527 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 12006559 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 19366992 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 8621625 | ||
| Pubmed | The Rab11-binding protein RELCH/KIAA1468 controls intracellular cholesterol distribution. | 2.44e-06 | 5 | 219 | 3 | 29514919 | |
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 18996923 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 7738026 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 17360453 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 8892527 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 7026729 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 10358022 | ||
| Pubmed | TANC2 IRF2BP2 SLC25A34 ITGA5 EHBP1L1 FGD5 TCF7 NACC1 MED8 USP24 IDH3B PPFIA3 SEC31B MED15 OSBP DSG4 | 3.36e-06 | 638 | 219 | 16 | 31182584 | |
| Pubmed | 3.50e-06 | 37 | 219 | 5 | 38011284 | ||
| Pubmed | 3.50e-06 | 37 | 219 | 5 | 20236931 | ||
| Pubmed | 4.86e-06 | 6 | 219 | 3 | 26807981 | ||
| Interaction | SCGB1A1 interactions | 5.94e-06 | 12 | 216 | 4 | int:SCGB1A1 | |
| Interaction | TOP3B interactions | TANC2 TBC1D9B ABL1 KMT2B ITGA5 SRCAP SAP30 MPRIP PCNX2 LONP1 EHBP1L1 AHNAK TMEM132A EXOSC6 SCN8A KBTBD11 SLC52A2 FLNA FLNC RARG APBA1 RELB NUBPL CCDC142 CELSR2 CDK13 NEK8 SAFB2 SNRPA CABIN1 AGRN IL4R ARHGAP33 EXOC4 TJP3 | 6.78e-06 | 1470 | 216 | 35 | int:TOP3B |
| Interaction | LAIR2 interactions | 1.35e-05 | 49 | 216 | 6 | int:LAIR2 | |
| Interaction | BGN interactions | 1.55e-05 | 30 | 216 | 5 | int:BGN | |
| Interaction | EP300 interactions | SOX2 ABL1 ZBTB48 MAZ MCL1 SRSF11 GCKR SRCAP STAT6 RTF1 ZNF469 KAT2B STXBP2 PURA CNTN2 FLNA RARA RARG USP24 PPIL4 IDH3A IDH3B ZBTB7B PPM1G PREB OSBP ARNT SLC25A10 SAFB2 AUTS2 DBR1 SNRPA SP7 | 1.61e-05 | 1401 | 216 | 33 | int:EP300 |
| Interaction | TCF12 interactions | 3.20e-05 | 148 | 216 | 9 | int:TCF12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 9.08e-07 | 37 | 219 | 5 | chr4q23 | |
| Cytoband | 4q23 | 2.30e-06 | 20 | 219 | 4 | 4q23 | |
| Cytoband | 1q21 | 7.86e-05 | 91 | 219 | 5 | 1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 2.17e-04 | 423 | 219 | 9 | chr12q13 | |
| Cytoband | 12q13 | 3.81e-04 | 71 | 219 | 4 | 12q13 | |
| GeneFamily | Collagens | COL26A1 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 | 1.48e-10 | 46 | 153 | 9 | 490 |
| GeneFamily | Alcohol dehydrogenases | 2.23e-09 | 8 | 153 | 5 | 397 | |
| GeneFamily | PDZ domain containing | 4.59e-05 | 152 | 153 | 8 | 1220 | |
| GeneFamily | Collagens|Collagen proteoglycans | 7.00e-04 | 5 | 153 | 2 | 575 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.19e-03 | 25 | 153 | 3 | 775 | |
| GeneFamily | EMI domain containing | 1.45e-03 | 7 | 153 | 2 | 540 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 2.46e-03 | 9 | 153 | 2 | 755 | |
| Coexpression | NABA_COLLAGENS | COL26A1 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 | 6.84e-11 | 43 | 217 | 9 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL26A1 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 | 8.53e-11 | 44 | 217 | 9 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL26A1 EMILIN2 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 LAMC2 VWA7 ELN AGRN | 6.45e-08 | 270 | 217 | 14 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL26A1 EMILIN2 COL24A1 COL1A2 COL4A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 LAMC2 VWA7 ELN AGRN | 8.10e-08 | 275 | 217 | 14 | M5884 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | TBC1D9B AHNAK COL4A2 COL4A6 FLNA FLNC TCF7 PODXL CELSR2 CSPG5 PCDH7 AGRN | 3.61e-06 | 276 | 217 | 12 | M3063 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 4.12e-06 | 111 | 217 | 8 | M45685 | |
| Coexpression | GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP | ZBTB48 PDLIM7 PDX1 ITGB3 PANK1 BHLHE22 BAIAP3 RARG AGRN ALDH7A1 | 7.03e-06 | 200 | 217 | 10 | M3529 |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_UP | 8.70e-06 | 88 | 217 | 7 | M5360 | |
| Coexpression | BMI1_DN.V1_UP | 3.23e-05 | 147 | 217 | 8 | M2782 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP | 4.30e-05 | 198 | 217 | 9 | M7902 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS | 4.45e-05 | 113 | 217 | 7 | M43610 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | SOX2 PDX1 HMX1 DNAJC6 PCNX2 FOXD4L1 KCNA5 SCN8A TACR3 SVOP KCNT1 CNTN2 ATP8B3 LAMC2 SLC8A2 CSPG5 | 4.50e-05 | 601 | 217 | 16 | MM866 |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 4.65e-05 | 200 | 217 | 9 | M6102 | |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN | 4.65e-05 | 200 | 217 | 9 | M6372 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN | 4.65e-05 | 200 | 217 | 9 | M6554 | |
| Coexpression | GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN | 4.65e-05 | 200 | 217 | 9 | M6567 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 PDLIM7 SOX8 SRCAP SCN8A RECK COL4A6 SEC16B FLNB COL9A1 COL11A2 COL16A1 BAZ2B IFFO1 APBA1 PMEL CUBN RFX5 MTMR4 SLC25A10 SNORC CABIN1 PCDH7 | 4.72e-05 | 1102 | 217 | 23 | M2369 |
| Coexpression | LIAO_METASTASIS | DNAJC6 SHKBP1 TMCO4 DNAJA4 SCN8A ALPK3 SLC52A2 COL1A2 FLNA COL11A2 CECR2 DNM1L CDK13 SNRPA AGRN | 4.85e-05 | 540 | 217 | 15 | M13809 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 PDLIM7 SOX8 SRCAP SCN8A RECK COL4A6 SEC16B FLNB COL9A1 COL11A2 COL16A1 BAZ2B IFFO1 APBA1 PMEL CUBN RFX5 MTMR4 SLC25A10 SNORC CABIN1 PCDH7 | 6.36e-05 | 1124 | 217 | 23 | MM1070 |
| Coexpression | LIU_PROSTATE_CANCER_DN | SRSF11 MYO15B FGD5 COL1A2 COL4A2 COL4A6 FLNA FLNC COL9A1 COL16A1 GPR161 CELSR2 EPHA2 PCDH7 | 6.86e-05 | 493 | 217 | 14 | M19391 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | PDX1 HMX1 PGAP6 PCNX2 SCN8A DIO3 KCNT1 CNTN2 FOXE1 COL9A2 YBX2 SLC8A2 SH3RF3 | 8.04e-05 | 438 | 217 | 13 | M1954 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | PDX1 HMX1 PGAP6 PCNX2 SCN8A DIO3 KCNT1 CNTN2 FOXE1 COL9A2 YBX2 SLC8A2 SH3RF3 | 8.42e-05 | 440 | 217 | 13 | MM832 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 9.23e-05 | 29 | 217 | 4 | MM17055 | |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | DENND2A RTF1 PCNX2 KAT2B FAM174A AHNAK CCNL2 COL4A6 FLNB COL16A1 IFFO1 LAMC2 RELB IDH3A IER3IP1 PBX3 KDSR IL4R | 9.93e-05 | 783 | 217 | 18 | M2488 |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | TBC1D9B PDLIM7 SLC25A34 NAB2 MCL1 SAP30 SHKBP1 LDHD COL24A1 KCNA5 MID1IP1 SLC49A3 ZMYND15 COL9A2 RARA BAZ2B COP1 RELB ZNF385A IDH3A LENG9 EPHA2 KCTD3 SLX4 | 1.17e-04 | 1250 | 217 | 24 | M41099 |
| Coexpression | FOURNIER_ACINAR_DEVELOPMENT_LATE_2 | 1.26e-04 | 281 | 217 | 10 | M4077 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | SOX2 PDX1 HMX1 DNAJC6 PCNX2 KCNA5 SCN8A TACR3 SVOP KCNT1 CNTN2 ATP8B3 LAMC2 SLC8A2 CSPG5 | 1.32e-04 | 591 | 217 | 15 | M2019 |
| CoexpressionAtlas | EB blastocyst_vs_EB bone marrow-Confounder_removed-fold2.0_adjp0.05 | SOX2 COL26A1 BACE2 BAIAP3 CNTN2 COL9A1 COL9A2 CECR2 SLC35F1 PMEL CELSR2 AUTS2 SMN1 ELN | 1.22e-05 | 345 | 215 | 14 | PCBC_ratio_EB blastocyst_vs_EB bone marrow_cfr-2X-p05 |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | SOX2 TBC1D9B SOX8 HMX1 SAP30 DGLUCY KAT2B SALL2 TMEM132A DIO3 BAIAP3 FOXE1 SLC37A1 ATP8B3 COL9A1 COL9A2 BAZ2B CECR2 APBA1 PMEL ZNF385A SEC31B RGS12 MTMR4 CELSR2 CSPG5 QTRT1 PCDH7 ARHGAP33 | 2.44e-05 | 1245 | 215 | 29 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | SOX8 COL24A1 HS3ST3A1 COL1A2 COL9A1 COL9A2 COL11A2 COL16A1 RARG ELN SNORC | 2.56e-09 | 188 | 219 | 11 | 7b1e3f8a941eaa68e89c562129a92314642eec66 |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | DENND2A PDLIM7 HS3ST3A1 COL1A2 COL4A2 COL4A6 FLNA FLNC COL16A1 ELN PCDH7 | 2.87e-09 | 190 | 219 | 11 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | SOX8 SHKBP1 HS3ST3A1 COL9A1 COL9A2 COL11A2 RARG AUTS2 SNORC PBX3 | 1.46e-08 | 172 | 219 | 10 | 415d57aa6278b8c12e7a2cf9c3fa5283389fb9b0 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.30e-08 | 197 | 219 | 10 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A PDLIM7 ITGA5 EHBP1L1 KCNA5 COL4A2 FLNC ELN PCDH7 SH3RF3 | 5.55e-08 | 198 | 219 | 10 | bd42c03e384e64f61b02618cf1a5440033bb04b2 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDLIM7 KCNA5 COL1A2 COL4A2 COL4A6 FLNA FLNC ELN PCDH7 SH3RF3 | 6.10e-08 | 200 | 219 | 10 | a66449b22b39dd6987fc2c3ed160d24564234ced |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-07 | 164 | 219 | 9 | 1d0d88132baaa3154c3e6e4ef0aff795afab08a2 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-07 | 164 | 219 | 9 | bd2e10b015d5e6a338675500ec5d81dc39583b3e | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.45e-07 | 177 | 219 | 9 | b01d7a6a78169962123ddfb0bb588f51d138ad02 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.57e-07 | 178 | 219 | 9 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.57e-07 | 178 | 219 | 9 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.10e-07 | 182 | 219 | 9 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SOX8 COL24A1 HS3ST3A1 COL9A1 COL9A2 COL11A2 COL16A1 RARG SNORC | 3.56e-07 | 185 | 219 | 9 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | DENND2A COL24A1 HS3ST3A1 COL1A2 COL4A2 COL16A1 ELN PBX3 SH3RF3 | 4.26e-07 | 189 | 219 | 9 | 44e37f88137bb249933eb615235b2cf2ae7f3925 |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-07 | 189 | 219 | 9 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DENND2A PDLIM7 COL24A1 HS3ST3A1 COL1A2 FLNA SLC35F1 ELN PCDH7 | 4.87e-07 | 192 | 219 | 9 | 992d08092edbc68c47b945deb8708379738c239a |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | DENND2A ABCA9 ADH1B COL24A1 HS3ST3A1 COL1A2 AUTS2 ELN SH3RF3 | 5.08e-07 | 193 | 219 | 9 | e6b75be08e33c1de079fb5c02f0b4468128b369c |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | DENND2A PDLIM7 ABCA9 COL24A1 HS3ST3A1 COL1A2 COL16A1 PCDH7 SH3RF3 | 5.31e-07 | 194 | 219 | 9 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.54e-07 | 195 | 219 | 9 | ae98215b7b7f22f1aca690920ce6092dc4a3c7db | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.54e-07 | 195 | 219 | 9 | 6fcab7aa4db958ccad0300adea9aaae52ace5bff | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 5.78e-07 | 196 | 219 | 9 | 1e9ccbd5be7839a74108f0cd07a6d2d736bc7f1b | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.04e-07 | 197 | 219 | 9 | 15a08b04acb1cb7e84aeb072c650ce07374181f5 | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|World / Cell class and subclass of bone marrow stroma cells in homeostatis | SOX8 HS3ST3A1 RECK COL9A1 COL9A2 COL11A2 COL16A1 AUTS2 SNORC | 6.04e-07 | 197 | 219 | 9 | a07ab2564ca7d577fd47f444dd7b0c25556e9fc4 |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.30e-07 | 198 | 219 | 9 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.30e-07 | 198 | 219 | 9 | e9f434bfd072e590fe44d518057ee5aa653038f3 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.30e-07 | 198 | 219 | 9 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | 18-Airway|18 / Age, Tissue, Lineage and Cell class | 6.30e-07 | 198 | 219 | 9 | 3cdfcc6445858c3c54058bbd90b20b88b1771cca | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.30e-07 | 198 | 219 | 9 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.57e-07 | 199 | 219 | 9 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | (02)_MMP9/10+-(1)_GFP|(02)_MMP9/10+ / shred by cell type by condition | 6.57e-07 | 199 | 219 | 9 | 448ba982be804007f991d469eca9d885b21ae499 | |
| ToppCell | 18-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 6.57e-07 | 199 | 219 | 9 | f5d0aa4170367c080d3c2f01d9af3529762917fa | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.85e-07 | 200 | 219 | 9 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.85e-07 | 200 | 219 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A ABCA9 ADH1B HS3ST3A1 COL1A2 COL4A2 COL9A1 COL11A2 COL16A1 | 6.85e-07 | 200 | 219 | 9 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-06 | 156 | 219 | 8 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-06 | 156 | 219 | 8 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.44e-06 | 162 | 219 | 8 | 25bb1b9709f960fdf90faff56e874f52a8f5d17e | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 3.16e-06 | 180 | 219 | 8 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.16e-06 | 180 | 219 | 8 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.16e-06 | 180 | 219 | 8 | 455d1e3ccf2ab609954f3b870e8f514ddca735f4 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.29e-06 | 181 | 219 | 8 | 8950844b3e65c7028d80da5787ae2ce509c3d52d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.29e-06 | 181 | 219 | 8 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.43e-06 | 182 | 219 | 8 | ed487f3a774812caa2903a646b60c86edcc1e65e | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 3.72e-06 | 184 | 219 | 8 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.87e-06 | 185 | 219 | 8 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-06 | 185 | 219 | 8 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.87e-06 | 185 | 219 | 8 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | (7)_MNP-(7)_DC_plasmacytoid|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.87e-06 | 185 | 219 | 8 | 9f67f652488e17075a372e2a2e1100f6d0af6d7d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.87e-06 | 185 | 219 | 8 | 0094f9baddb20214d2a2c166f1637d1a9cf1169a | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.36e-06 | 188 | 219 | 8 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.36e-06 | 188 | 219 | 8 | 9b95730ddd13eb4624321bab3ab4989414977ca3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.53e-06 | 189 | 219 | 8 | 55aba1ebc012006a5db3ff9c92589cb3d9f7c68a | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.71e-06 | 190 | 219 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.90e-06 | 191 | 219 | 8 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 4.90e-06 | 191 | 219 | 8 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 4.90e-06 | 191 | 219 | 8 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-arterial_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.90e-06 | 191 | 219 | 8 | 0b022d8b39eac36115b269aac11a5eaa492754cc | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.09e-06 | 192 | 219 | 8 | dee97f650ae6f4d07a142ade402aae1905791a22 | |
| ToppCell | (6)_Endothelial-B_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.49e-06 | 194 | 219 | 8 | 0cf4e67d4024652794b5bfdd4a71a7d98900b4c8 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.49e-06 | 194 | 219 | 8 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.49e-06 | 194 | 219 | 8 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.49e-06 | 194 | 219 | 8 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-06 | 195 | 219 | 8 | b3660779f274ca97dd844cf83f62d85ba88cb182 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-06 | 195 | 219 | 8 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | 15-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 5.70e-06 | 195 | 219 | 8 | 414f60bc0f0d0ecb5137bcd617fae91f0c15038a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.70e-06 | 195 | 219 | 8 | b0d408f8bc1701a87596ed55efcd90749fee33e6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-06 | 195 | 219 | 8 | 7155cc12cc6a97efd626bbdb95249fb3d7041dcf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-06 | 195 | 219 | 8 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-06 | 195 | 219 | 8 | a52ee3ad6cd317f10b9308450517861ef2e363bb | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.70e-06 | 195 | 219 | 8 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.70e-06 | 195 | 219 | 8 | a486a7acea0e91048cc48afa0dbd3926d30bc217 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.92e-06 | 196 | 219 | 8 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.92e-06 | 196 | 219 | 8 | 40cae477b3906623d1f2a4c630279e710499ce80 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.92e-06 | 196 | 219 | 8 | 629236f95c838a473b5964a49b7c1b7ad863ea12 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.14e-06 | 197 | 219 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-06 | 197 | 219 | 8 | 78d45d11820ec379942c4c3defd619d5f8cc8e1f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-06 | 197 | 219 | 8 | 31bc9fd679d78550541d4158568e8dd09ff29e8e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-06 | 197 | 219 | 8 | 16758f181ef07c60aee63072e1da9572c5c85414 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 6.14e-06 | 197 | 219 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.38e-06 | 198 | 219 | 8 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD8+_T_naive|URO / Disease, condition lineage and cell class | 6.38e-06 | 198 | 219 | 8 | c07426d4119b53e58eb5f448ae364f47cac1fc5c | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.38e-06 | 198 | 219 | 8 | bba40ece261741fa8c0e28de768af001d28f04f8 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.38e-06 | 198 | 219 | 8 | 8a55589b9244283e4b0b423a4a6d6202e8e0fec9 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.38e-06 | 198 | 219 | 8 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.38e-06 | 198 | 219 | 8 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.38e-06 | 198 | 219 | 8 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.38e-06 | 198 | 219 | 8 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.38e-06 | 198 | 219 | 8 | e967c601101361fc1c48dab0e5b76dc68813276e | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.62e-06 | 199 | 219 | 8 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.62e-06 | 199 | 219 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.62e-06 | 199 | 219 | 8 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 6.62e-06 | 199 | 219 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.62e-06 | 199 | 219 | 8 | 1f5ad0f1971156b28a8d46a380bda906b5fdbedc | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.62e-06 | 199 | 219 | 8 | 08bdcabc3fce787578a8eb66fc8412b0974fa6cc | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.62e-06 | 199 | 219 | 8 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.86e-06 | 200 | 219 | 8 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.86e-06 | 200 | 219 | 8 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-06 | 200 | 219 | 8 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-06 | 200 | 219 | 8 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.86e-06 | 200 | 219 | 8 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 3.44e-09 | 15 | 219 | 6 | CID000440673 | |
| Drug | strontium ranelate | ATP6V1A ADH1A COL24A1 COL1A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 PMEL | 3.45e-09 | 77 | 219 | 10 | CID006918182 |
| Drug | 2-NA | 9.61e-09 | 9 | 219 | 5 | CID000074128 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 9.61e-09 | 9 | 219 | 5 | CID000440672 | |
| Drug | GK-101 | 4.56e-08 | 36 | 219 | 7 | CID000161853 | |
| Drug | AC1L1J0I | 5.90e-08 | 12 | 219 | 5 | CID000030201 | |
| Drug | hexa-2,4-dien-1-ol | 5.90e-08 | 12 | 219 | 5 | CID000008104 | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | ZBTB48 PDLIM7 MAZ ITGA5 SRCAP MAST4 TMEM132A ASPSCR1 PPFIA3 ARNT CTPS1 IFI6 AGRN | 6.43e-08 | 197 | 219 | 13 | 5227_DN |
| Drug | 2-naphthaldehyde | 9.51e-08 | 13 | 219 | 5 | CID000006201 | |
| Drug | AC1L1C2F | ITGA5 COL24A1 SALL2 COL1A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 LAMC2 | 1.12e-07 | 110 | 219 | 10 | CID000001711 |
| Drug | halofuginone lactate | COL24A1 ASPSCR1 COL1A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 RELB | 1.31e-07 | 85 | 219 | 9 | CID000062891 |
| Drug | AC1LAKND | 1.40e-07 | 62 | 219 | 8 | CID000470146 | |
| Drug | PPACK | ITGB3 COL24A1 SLC52A2 COL1A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 RELB | 1.45e-07 | 113 | 219 | 10 | CID003036757 |
| Drug | naphthalenemethanol | 1.47e-07 | 14 | 219 | 5 | CID000020908 | |
| Drug | Madecassol | 2.69e-07 | 46 | 219 | 7 | CID000108062 | |
| Drug | naphthaldehyde | 3.15e-07 | 16 | 219 | 5 | CID000006195 | |
| Drug | BAPN | 4.08e-07 | 71 | 219 | 8 | CID000001647 | |
| Drug | d-indobufen | 4.87e-07 | 50 | 219 | 7 | CID000044562 | |
| Drug | N-heptylformamide | 5.66e-07 | 8 | 219 | 4 | CID000347402 | |
| Drug | DMSe | COL24A1 COL1A2 COL4A6 FLNA COL9A1 COL9A2 COL11A2 COL16A1 CELSR2 ELN | 6.20e-07 | 132 | 219 | 10 | CID000020796 |
| Drug | ridogrel | 6.41e-07 | 52 | 219 | 7 | CID005362391 | |
| Drug | NSC49633 | 7.33e-07 | 53 | 219 | 7 | CID000023340 | |
| Drug | 4-Iodopyrazole | 8.78e-07 | 3 | 219 | 3 | DB02721 | |
| Drug | AC1Q6PCP | ITGB3 COL24A1 KLK9 COL1A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 RELB OSBP SAFB2 | 2.52e-06 | 230 | 219 | 12 | CID000005267 |
| Drug | 4-hydroxyproline | 2.76e-06 | 91 | 219 | 8 | CID000000825 | |
| Drug | W-13, hydrochloride; Up 200; 10uM; MCF7; HG-U133A | PDLIM7 MAZ ITGA5 SLC52A2 FLNA RARA IFFO1 MED15 SAFB2 AGRN TJP3 | 3.00e-06 | 194 | 219 | 11 | 440_UP |
| Drug | Selara | ADH1A COL24A1 COL1A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 RELB | 3.48e-06 | 125 | 219 | 9 | CID000150310 |
| Drug | Fomepizole | 3.49e-06 | 4 | 219 | 3 | DB01213 | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 1uM; MCF7; HT_HG-U133A | SOX2 SIGLEC5 CBARP DNAJC6 ITGB3 AHNAK TMPRSS11D COL4A2 APBA1 IFI6 ALDH7A1 | 3.65e-06 | 198 | 219 | 11 | 3908_UP |
| Drug | malotilate | 5.46e-06 | 71 | 219 | 7 | CID000004006 | |
| Drug | ticlopidine | 7.00e-06 | 103 | 219 | 8 | CID000005472 | |
| Drug | dhmal | 7.74e-06 | 29 | 219 | 5 | CID000151725 | |
| Drug | AC1NMZ1B | 7.89e-06 | 75 | 219 | 7 | CID005034185 | |
| Drug | PCR 4099 | ITGB3 COL24A1 SLC52A2 COL1A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 | 8.31e-06 | 139 | 219 | 9 | CID000002806 |
| Drug | AC1L1AOQ | 9.21e-06 | 30 | 219 | 5 | CID000001082 | |
| Drug | 40-a | 9.21e-06 | 30 | 219 | 5 | CID000211218 | |
| Drug | hydroxylysine | 1.06e-05 | 109 | 219 | 8 | CID000001029 | |
| Drug | willardine | 1.28e-05 | 32 | 219 | 5 | CID000005123 | |
| Drug | phenoxyethanol | 1.38e-05 | 16 | 219 | 4 | CID000031236 | |
| Drug | Grgds | 1.55e-05 | 83 | 219 | 7 | CID000123811 | |
| Drug | Azacytidine-5 [320-67-2]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 1.63e-05 | 190 | 219 | 10 | 4128_DN | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; HL60; HT_HG-U133A | 1.70e-05 | 191 | 219 | 10 | 3123_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.86e-05 | 193 | 219 | 10 | 4322_UP | |
| Drug | CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A | KMT2B PDLIM7 MAZ SRCAP SAP30 ASPSCR1 PPFIA3 SAFB2 CABIN1 ALDH7A1 | 1.95e-05 | 194 | 219 | 10 | 6417_DN |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.04e-05 | 195 | 219 | 10 | 7435_UP | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A | 2.04e-05 | 195 | 219 | 10 | 2875_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A | PDLIM7 MAZ NAB2 PHLPP1 ASPSCR1 COL4A6 RARA CDK13 CABIN1 AGRN | 2.13e-05 | 196 | 219 | 10 | 4292_DN |
| Drug | 3-Acetamidocoumarin [779-30-6]; Down 200; 19.6uM; HL60; HT_HG-U133A | PDLIM7 CLCN4 ASPSCR1 COL4A2 FLNB RELB MED15 ARNT CELSR2 IFI6 | 2.13e-05 | 196 | 219 | 10 | 2941_DN |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | DENND2A TBC1D9B ZBTB48 NAB2 MCL1 SRCAP DNAJC6 CLCN4 SAFB2 CABIN1 | 2.13e-05 | 196 | 219 | 10 | 5081_DN |
| Drug | Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | TBC1D9B ZBTB48 SRSF11 ITGA5 SALL2 MAST4 SLC37A1 RARA CDK13 EPHA2 | 2.22e-05 | 197 | 219 | 10 | 7186_DN |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A | 2.32e-05 | 198 | 219 | 10 | 2246_DN | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; PC3; HT_HG-U133A | MAGI1 NAB2 ETV3 SRCAP PCNX2 MYOZ1 DNAJA4 AHNAK BAIAP3 SLC8A2 | 2.32e-05 | 198 | 219 | 10 | 5095_UP |
| Drug | Dacarbazine [4342-03-4]; Down 200; 22uM; MCF7; HT_HG-U133A | 2.32e-05 | 198 | 219 | 10 | 6816_DN | |
| Drug | DOPEG | 2.33e-05 | 36 | 219 | 5 | CID000091528 | |
| Drug | Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.42e-05 | 199 | 219 | 10 | 5286_UP | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 2.42e-05 | 199 | 219 | 10 | 5931_UP | |
| Drug | L-lysyl-L-lysyl-L-lysine | ITGB3 COL24A1 KLK9 COL1A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 | 2.83e-05 | 162 | 219 | 9 | CID000072363 |
| Drug | C x F | 2.88e-05 | 19 | 219 | 4 | CID000013017 | |
| Drug | Ethanol | 2.99e-05 | 7 | 219 | 3 | DB00898 | |
| Drug | Methamphetamine | MAGI1 GRIPAP1 ABL1 PDLIM7 NAB2 GLYCTK MCL1 PGAP6 STAT6 MPRIP LDHD EHBP1L1 DNAJA4 AHNAK PHLPP1 MYO18B BAIAP3 CNTN2 FOXE1 CCNL2 FLNA FLNB FLNC RARG PODXL IDH3A CUBN CABIN1 SH3RF3 AGRN | 3.29e-05 | 1401 | 219 | 30 | ctd:D008694 |
| Drug | AC1L85AO | 4.15e-05 | 66 | 219 | 6 | CID000372705 | |
| Drug | Ethylene Glycol | 4.38e-05 | 21 | 219 | 4 | ctd:D019855 | |
| Drug | 5-butyl-2-phenoxyphenol | 4.74e-05 | 8 | 219 | 3 | CID005274975 | |
| Drug | AC1NBLOP | 4.74e-05 | 8 | 219 | 3 | CID004469995 | |
| Drug | DL-penicillamine | 6.17e-05 | 139 | 219 | 8 | CID000004727 | |
| Drug | AC1O5U0X | 7.61e-05 | 24 | 219 | 4 | CID006440684 | |
| Drug | 2-butoxyethanol | 7.61e-05 | 24 | 219 | 4 | CID000008133 | |
| Drug | AC1L9K70 | 7.65e-05 | 228 | 219 | 10 | CID000446871 | |
| Drug | candesartan cilexetil | 8.31e-05 | 145 | 219 | 8 | CID000002540 | |
| Drug | Sp 1 (pharmaceutical) | SP4 MAZ NAB2 POGZ SRCAP SAP30 KAT2B PURA TMPRSS11D BACE2 COL1A2 TCF7 LAMC2 RELB SAFB2 SP7 | 8.72e-05 | 548 | 219 | 16 | CID000099040 |
| Drug | 3-(3-(3-(4,5-dihydroimidazol-2-ylamino)propyloxylisoxazol-5-yl)carbonylamino)-2-(phenylsulfonylamino)propionic acid | 9.21e-05 | 2 | 219 | 2 | ctd:C426703 | |
| Drug | technetium 99m (HYNIC-3PRGD(2))(tricine)(TPPTS) | 9.21e-05 | 2 | 219 | 2 | ctd:C561921 | |
| Drug | 3-(6-methoxypyridin-3-yl)-3-(2-oxo-3-(3-(5,6,7,8-tetrahydro(1,8)naphthyridin-2-yl)propyl)imidazolidin-1-yl)propionic acid | 9.21e-05 | 2 | 219 | 2 | ctd:C478626 | |
| Drug | Ethylene Glycols | 9.21e-05 | 2 | 219 | 2 | ctd:D005026 | |
| Drug | Cyclohexylformamide | 9.21e-05 | 2 | 219 | 2 | DB03559 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | ITGA5 COL24A1 COL1A2 COL4A6 COL9A1 COL9A2 COL11A2 COL16A1 MED15 | 9.38e-05 | 189 | 219 | 9 | CID000001413 |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 1.02e-04 | 191 | 219 | 9 | 3803_DN | |
| Drug | 4-methylpiperazine-2,6-dione | 1.05e-04 | 26 | 219 | 4 | CID000124723 | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.06e-04 | 192 | 219 | 9 | 1638_DN | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.06e-04 | 192 | 219 | 9 | 4303_UP | |
| Drug | CG-R | 1.06e-04 | 49 | 219 | 5 | CID011987895 | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.10e-04 | 193 | 219 | 9 | 4202_DN | |
| Drug | Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.14e-04 | 194 | 219 | 9 | 2632_DN | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; HL60; HG-U133A | 1.14e-04 | 194 | 219 | 9 | 1748_DN | |
| Drug | Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.14e-04 | 194 | 219 | 9 | 7164_UP | |
| Drug | Butoconazole nitrate [32872-77-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.19e-04 | 195 | 219 | 9 | 6288_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.19e-04 | 195 | 219 | 9 | 3408_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.19e-04 | 195 | 219 | 9 | 7172_DN | |
| Drug | Propofol [2078-54-8]; Down 200; 22.4uM; PC3; HT_HG-U133A | 1.19e-04 | 195 | 219 | 9 | 6707_DN | |
| Drug | AC1L9732 | 1.19e-04 | 114 | 219 | 7 | CID000439300 | |
| Drug | fomepizole | 1.23e-04 | 27 | 219 | 4 | ctd:C010238 | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; HL60; HT_HG-U133A | 1.24e-04 | 196 | 219 | 9 | 1852_UP | |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; HL60; HT_HG-U133A | 1.24e-04 | 196 | 219 | 9 | 2393_DN | |
| Drug | Methotrexate [59-05-2]; Up 200; 8.8uM; PC3; HT_HG-U133A | DENND2A PGAP6 ITGB3 AHNAK KBTBD11 RARG IFFO1 PPFIA3 HNRNPUL2 | 1.24e-04 | 196 | 219 | 9 | 6318_UP |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.24e-04 | 196 | 219 | 9 | 6014_DN | |
| Drug | Tranilast sodium | 1.26e-04 | 115 | 219 | 7 | CID000005527 | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; PC3; HT_HG-U133A | 1.28e-04 | 197 | 219 | 9 | 4183_DN | |
| Drug | Napelline [5008-52-6]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.28e-04 | 197 | 219 | 9 | 2522_DN | |
| Drug | Loracarbef [121961-22-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 219 | 9 | 3532_DN | |
| Drug | Cyanocobalamin [68-19-9]; Up 200; 3uM; HL60; HT_HG-U133A | 1.28e-04 | 197 | 219 | 9 | 1315_UP | |
| Disease | alcohol dependence measurement | 1.23e-07 | 55 | 209 | 7 | EFO_0007835 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.82e-07 | 19 | 209 | 5 | DOID:2256 (is_implicated_in) | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 2.27e-07 | 37 | 209 | 6 | EFO_0007645, EFO_0009458 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 3.50e-07 | 3 | 209 | 3 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 3.50e-07 | 3 | 209 | 3 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Stickler syndrome | 3.47e-06 | 5 | 209 | 3 | cv:C0265253 | |
| Disease | Alcohol Use Disorder | 1.47e-05 | 44 | 209 | 5 | C0001956 | |
| Disease | myopathy (implicated_via_orthology) | 2.27e-05 | 48 | 209 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | alcohol use disorder measurement, alcohol dependence | 2.33e-05 | 24 | 209 | 4 | EFO_0009458, MONDO_0007079 | |
| Disease | Congenital ocular coloboma (disorder) | 2.85e-05 | 9 | 209 | 3 | C0009363 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.70e-05 | 53 | 209 | 5 | C4707243 | |
| Disease | Solitary fibrous tumor | 4.99e-05 | 2 | 209 | 2 | C1266119 | |
| Disease | hemangiopericytoma | 4.99e-05 | 2 | 209 | 2 | C0018922 | |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 5.54e-05 | 11 | 209 | 3 | DOID:0050709 (implicated_via_orthology) | |
| Disease | Connective Tissue Diseases | 9.51e-05 | 13 | 209 | 3 | C0009782 | |
| Disease | Stickler syndrome (disorder) | 1.49e-04 | 3 | 209 | 2 | C0265253 | |
| Disease | Atypical juvenile parkinsonism | 1.49e-04 | 3 | 209 | 2 | C4510873 | |
| Disease | Disproportionate short stature | 2.22e-04 | 77 | 209 | 5 | C0878659 | |
| Disease | Cleft Palate | 2.81e-04 | 81 | 209 | 5 | C0008925 | |
| Disease | palmitoleoyl-protein carboxylesterase NOTUM measurement | 2.97e-04 | 4 | 209 | 2 | EFO_0802842 | |
| Disease | Stickler syndrome (is_implicated_in) | 2.97e-04 | 4 | 209 | 2 | DOID:0080046 (is_implicated_in) | |
| Disease | Multiple Epiphyseal Dysplasia | 3.65e-04 | 20 | 209 | 3 | C0026760 | |
| Disease | bitter alcoholic beverage consumption measurement | 3.82e-04 | 133 | 209 | 6 | EFO_0010092 | |
| Disease | C-peptide measurement | 4.88e-04 | 22 | 209 | 3 | EFO_0005187 | |
| Disease | Alcohol dependence | 4.92e-04 | 5 | 209 | 2 | cv:C0001973 | |
| Disease | Malignant Cystosarcoma Phyllodes | 4.92e-04 | 5 | 209 | 2 | C0600066 | |
| Disease | ALCOHOL DEPENDENCE | 4.92e-04 | 5 | 209 | 2 | 103780 | |
| Disease | Multiple Epiphyseal Dysplasia, Dominant | 4.92e-04 | 5 | 209 | 2 | cv:CN043640 | |
| Disease | Phyllodes Tumor | 4.92e-04 | 5 | 209 | 2 | C0010701 | |
| Disease | insulin-like growth factor-binding protein 1 measurement | 4.92e-04 | 5 | 209 | 2 | EFO_0020474 | |
| Disease | Neurodevelopmental Disorders | 5.33e-04 | 93 | 209 | 5 | C1535926 | |
| Disease | Sensorineural Hearing Loss (disorder) | 5.59e-04 | 23 | 209 | 3 | C0018784 | |
| Disease | vitamin D measurement | 6.97e-04 | 336 | 209 | 9 | EFO_0004631 | |
| Disease | Left ventricular mass to end-diastolic volume ratio | 7.18e-04 | 25 | 209 | 3 | EFO_0010556 | |
| Disease | contactin-1 measurement | 7.35e-04 | 6 | 209 | 2 | EFO_0020286 | |
| Disease | Congenital musculoskeletal anomalies | 7.35e-04 | 6 | 209 | 2 | C0151491 | |
| Disease | Disorder of eye | 8.23e-04 | 212 | 209 | 7 | C0015397 | |
| Disease | serum gamma-glutamyl transferase measurement | PDX1 MCL1 GCKR PGAP6 MPRIP ADH1B KAT2B AHNAK SEC16B PPM1G CELSR2 EPHA2 SLC25A10 CABIN1 EXOC4 TJP3 | 8.55e-04 | 914 | 209 | 16 | EFO_0004532 |
| Disease | alcohol use disorder measurement | 8.69e-04 | 214 | 209 | 7 | EFO_0009458 | |
| Disease | Uveoretinal Coloboma | 1.02e-03 | 7 | 209 | 2 | C4554007 | |
| Disease | group XIIB secretory phospholipase A2-like protein measurement | 1.02e-03 | 7 | 209 | 2 | EFO_0801657 | |
| Disease | Early Pregnancy Loss | 1.09e-03 | 109 | 209 | 5 | C3830362 | |
| Disease | Spontaneous abortion | 1.09e-03 | 109 | 209 | 5 | C0000786 | |
| Disease | Miscarriage | 1.09e-03 | 109 | 209 | 5 | C4552766 | |
| Disease | Epilepsy | 1.09e-03 | 109 | 209 | 5 | C0014544 | |
| Disease | Abortion, Tubal | 1.09e-03 | 109 | 209 | 5 | C0000822 | |
| Disease | Alcohol abuse | 1.32e-03 | 67 | 209 | 4 | C0085762 | |
| Disease | Mitochondrial Encephalomyopathies | 1.36e-03 | 8 | 209 | 2 | C0162666 | |
| Disease | Large cell carcinoma of lung | 1.49e-03 | 32 | 209 | 3 | C0345958 | |
| Disease | Squamous cell carcinoma of lung | 1.49e-03 | 32 | 209 | 3 | C0149782 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.64e-03 | 239 | 209 | 7 | EFO_0010934 | |
| Disease | Oxidative Phosphorylation Deficiencies | 1.74e-03 | 9 | 209 | 2 | C0949856 | |
| Disease | Mitochondrial Respiratory Chain Deficiencies | 1.74e-03 | 9 | 209 | 2 | C0949857 | |
| Disease | Electron Transport Chain Deficiencies, Mitochondrial | 1.74e-03 | 9 | 209 | 2 | C0949855 | |
| Disease | glycolipid transfer protein domain-containing protein 2 measurement | 1.74e-03 | 9 | 209 | 2 | EFO_0801643 | |
| Disease | bullous pemphigoid | 1.78e-03 | 34 | 209 | 3 | EFO_0007187 | |
| Disease | testosterone measurement | MAGI1 IRF2BP2 GLYCTK GCKR SRCAP ADH1B ADH6 KAT2B TACR3 SVOP COL4A2 ATP8B3 UBQLN2 CECR2 ZBTB7B ARNT IER3IP1 AUTS2 CTPS1 | 1.90e-03 | 1275 | 209 | 19 | EFO_0004908 |
| Disease | Osteogenesis imperfecta type IV (disorder) | 2.16e-03 | 10 | 209 | 2 | C0268363 | |
| Disease | protein intake measurement | 2.16e-03 | 10 | 209 | 2 | EFO_0010810 | |
| Disease | parasitemia measurement | 2.28e-03 | 37 | 209 | 3 | EFO_0005528 | |
| Disease | age-related hearing impairment | 2.28e-03 | 324 | 209 | 8 | EFO_0005782 | |
| Disease | cortical thickness | MAGI1 IRF2BP2 KMT2B COL26A1 ZNF469 MAST4 KCNA5 UMODL1 COL4A2 FLNB MEGF9 KCTD3 AUTS2 ELN PCDH7 SH3RF3 EXOC4 | 2.54e-03 | 1113 | 209 | 17 | EFO_0004840 |
| Disease | Sensory hearing loss | 2.63e-03 | 11 | 209 | 2 | C1691779 | |
| Disease | atopic dermatitis (implicated_via_orthology) | 2.63e-03 | 11 | 209 | 2 | DOID:3310 (implicated_via_orthology) | |
| Disease | Epilepsy, Cryptogenic | 2.78e-03 | 82 | 209 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 2.78e-03 | 82 | 209 | 4 | C0751111 | |
| Disease | Aura | 2.78e-03 | 82 | 209 | 4 | C0236018 | |
| Disease | kidney disease (implicated_via_orthology) | 3.06e-03 | 41 | 209 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | cognitive function measurement | TANC2 MAGI1 IRF2BP2 SP4 GIPC2 PDLIM7 MAST4 TMPRSS11D PHLPP1 SLC49A3 MYO18B BACE2 COL4A2 SEC16B RARG APBA1 AUTS2 PCDH7 SH3RF3 EXOC4 | 3.10e-03 | 1434 | 209 | 20 | EFO_0008354 |
| Disease | cleft palate (is_implicated_in) | 3.14e-03 | 12 | 209 | 2 | DOID:674 (is_implicated_in) | |
| Disease | papillary thyroid carcinoma | 3.14e-03 | 12 | 209 | 2 | EFO_0000641 | |
| Disease | alcohol consumption measurement, alcohol drinking | 3.14e-03 | 12 | 209 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | alcohol consumption measurement | MAGI1 GCKR STAT6 ADH1A ADH1B ADH1C ADH4 ADH6 MAST4 SCN8A ASPSCR1 SVOP LAMC2 RGS12 PPM1G MEGF9 AUTS2 AGRN | 3.34e-03 | 1242 | 209 | 18 | EFO_0007878 |
| Disease | bipolar I disorder | 3.37e-03 | 141 | 209 | 5 | EFO_0009963 | |
| Disease | left ventricular structural measurement | 3.59e-03 | 88 | 209 | 4 | EFO_0008205 | |
| Disease | extracellular matrix protein 1 measurement | 3.70e-03 | 13 | 209 | 2 | EFO_0008126 | |
| Disease | prostate carcinoma (is_implicated_in) | 3.70e-03 | 13 | 209 | 2 | DOID:10286 (is_implicated_in) | |
| Disease | receptive language perception, parental genotype effect measurement | 4.30e-03 | 14 | 209 | 2 | EFO_0005686, EFO_0005939 | |
| Disease | Sarcoma, Spindle Cell | 4.30e-03 | 14 | 209 | 2 | C0205945 | |
| Disease | Sarcoma, Epithelioid | 4.30e-03 | 14 | 209 | 2 | C0205944 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 4.80e-03 | 447 | 209 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | Hypertriglyceridemia | 4.93e-03 | 15 | 209 | 2 | C0020557 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 5.07e-03 | 97 | 209 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 5.16e-03 | 222 | 209 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | prostate cancer (is_marker_for) | 5.17e-03 | 156 | 209 | 5 | DOID:10283 (is_marker_for) | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 5.50e-03 | 225 | 209 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | Tremor, Rubral | 5.61e-03 | 16 | 209 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 5.61e-03 | 16 | 209 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 5.61e-03 | 16 | 209 | 2 | C0278161 | |
| Disease | alcohol use disorder (is_implicated_in) | 5.61e-03 | 16 | 209 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | Spondyloepiphyseal Dysplasia | 5.61e-03 | 16 | 209 | 2 | C0038015 | |
| Disease | Ataxia, Sensory | 5.61e-03 | 16 | 209 | 2 | C0240991 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 5.61e-03 | 16 | 209 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 5.61e-03 | 16 | 209 | 2 | C4551479 | |
| Disease | central nervous system disease (implicated_via_orthology) | 5.61e-03 | 16 | 209 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | Abnormal coordination | 5.61e-03 | 16 | 209 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 5.61e-03 | 16 | 209 | 2 | C0427190 | |
| Disease | diacylglycerol 44:7 measurement | 5.61e-03 | 16 | 209 | 2 | EFO_0020069 | |
| Disease | Schwartz-Jampel Syndrome | 5.61e-03 | 16 | 209 | 2 | C0036391 | |
| Disease | Drug-induced agranulocytosis | 5.61e-03 | 16 | 209 | 2 | HP_0012235 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGLSAATGVTVPGLG | 561 | Q5DID0 | |
| LPAVPGGTSGIDGGQ | 566 | Q8N6Y0 | |
| IPETGQGVTKGEGGT | 166 | Q96PM9 | |
| GEAGPGSGAGTVLQF | 276 | Q8N350 | |
| SGPGIQGGGAIVQRA | 26 | P27540 | |
| GVAQAAGSGGLGGPV | 51 | Q8NHY2 | |
| GLPVAGSGTNGGSLV | 236 | Q9Y5Z0 | |
| GSGTNGGSLVLGGIE | 241 | Q9Y5Z0 | |
| GGGGSAVSVLAPNGR | 6 | Q9BZE9 | |
| GDSGSQGFRGVIGEP | 561 | Q14031 | |
| PGLGGVTAEAGSGDA | 106 | O95196 | |
| ASGGGGVGDGVQEPT | 571 | O00429 | |
| GLGGVTGVARPQVGG | 1121 | O94812 | |
| PTSGAEIGGAFGGEK | 486 | P49419 | |
| TPGSTCAVFGLGGVG | 191 | P07327 | |
| TPGSTCAVFGLGGVG | 196 | P08319 | |
| TPGSTCAVFGLGGVG | 191 | P28332 | |
| GDIGIGIAGENGLPG | 1521 | Q07092 | |
| TAGQVILKGSGGGEP | 1346 | Q8IUA7 | |
| GGVGVPGLLVGSAGV | 96 | Q8NFJ8 | |
| VPSLGSGLGLSEGNG | 1651 | Q9UIF8 | |
| TPGSTCAVFGLGGVG | 191 | P00325 | |
| TPGSTCAVFGLGGVG | 191 | P00326 | |
| GEQAAGLAAVPQGGS | 66 | P0C2W7 | |
| VDPVSSRNAIGGGGI | 206 | P41162 | |
| PGNRDGLVAAGATGG | 381 | Q96PJ5 | |
| ELGIGPGAATRGSGV | 1531 | O00468 | |
| GGESQVGAATGGLVP | 1181 | Q96L96 | |
| AGDEGGGQSLVSPGS | 1631 | P08572 | |
| AGAISASGPELQGAG | 226 | Q09666 | |
| TAGLVEGEPTGAGGG | 16 | Q8TF65 | |
| PGLLGLVGGVAGSAS | 276 | Q17RM4 | |
| EGSGPAGIRGGETVI | 36 | O60423 | |
| AAGVSVAFGAPIGGV | 261 | P51793 | |
| PSQAEGGEGGVACGT | 141 | Q6NUI1 | |
| QGGEQAIKEGGSGSP | 66 | Q8WW22 | |
| NITVGGIPGPAGGVA | 1741 | Q9HCU4 | |
| QGSAGSGAIGPVEAA | 21 | Q9Y3E2 | |
| PVGTGGVQLCGGGST | 371 | Q15517 | |
| GSVSGLAGGFVGTPA | 106 | Q9UBX3 | |
| GVIGEASPCGSEGKG | 1076 | Q9BXF3 | |
| LEEGVSGESLPGAGG | 136 | Q8IWY9 | |
| GGGASSGGGVTPLVE | 131 | Q14004 | |
| NSEGLDTLSGQPGGG | 416 | P10276 | |
| SSEDEVPGGQGKGGL | 436 | P13631 | |
| GTENREVGIGGDQGP | 411 | P48382 | |
| VCSGGAGAVVGETPG | 516 | Q01201 | |
| VAEVAGGLAPGSAGA | 21 | O95980 | |
| DQGIGGFGEEPGIKS | 36 | Q9Y5U9 | |
| IQTGDPTGTGRGGES | 51 | Q8WUA2 | |
| PTGTGRGGESIFGQL | 56 | Q8WUA2 | |
| RLVPGTGTGIVCGSG | 176 | A6NJW4 | |
| AGGREPSTASGGGQL | 161 | Q9P260 | |
| LAEGVSGPEKGGGSA | 116 | P40426 | |
| GPVNTTVARGGGSGN | 101 | O00592 | |
| TGDGGGEATGSPLAQ | 881 | Q6WCQ1 | |
| PGLDNDVGVEVGGSG | 46 | Q9NPA3 | |
| SGGGGGSGVVSTVVQ | 981 | Q96QZ7 | |
| TAVAAAGTAEGPGGG | 56 | Q92831 | |
| EGTGSGGLLPQSGAL | 2186 | Q6PRD1 | |
| VPEGTGAGGLAAGGT | 216 | Q15742 | |
| VGEGEGSQGASGPAA | 11 | P55073 | |
| QVAGLLGSGEGGLTE | 221 | Q5RKV6 | |
| GDGQTLANGLGPGGD | 216 | O75145 | |
| GLTPGSGGLGNVDEE | 4176 | Q2LD37 | |
| GGGSVGSDVGQRLPV | 41 | Q5JUK3 | |
| SNPEGGAGSELIFGG | 221 | P14091 | |
| AGGTVEGGVSGVELN | 721 | Q86SJ6 | |
| GGLGIGEGAPEIVTG | 121 | Q96MX6 | |
| AGIGGLGITVEGPSE | 1356 | O75369 | |
| GNIEDVDGGGAPTTG | 1881 | A6NKB5 | |
| GGTAVGGGGVAEPEQ | 211 | P52945 | |
| GGKEAQALGVPGGSA | 276 | Q96B70 | |
| GIAGLSAGVTGITGP | 5691 | Q7Z5P9 | |
| ELLQEPGGGGSGGES | 181 | O60245 | |
| GSSAPGIGGAAEEVG | 506 | Q6ZNL6 | |
| GTGGLGLTVEGPCEA | 1091 | Q14315 | |
| PAAAGETRGGVGVGG | 186 | Q9NP08 | |
| PAEATAGSGGVNGGE | 131 | Q1KMD3 | |
| VGGNAFGGLGNPSVT | 756 | Q8WXX7 | |
| FGSGGGDKGPVVAAQ | 456 | P13942 | |
| PGIEGTGLEQGPSVG | 516 | Q8N3D4 | |
| QSLTGGPAAGAAGIG | 86 | Q96RN5 | |
| LGAGGGSLLPGAVEQ | 361 | Q86SG6 | |
| LSVPQLSGAGGGGGE | 236 | P56270 | |
| VTGGGGAAGQVDASP | 41 | Q9H1U4 | |
| GAGGSAGAGEGPVIT | 96 | P36776 | |
| GPVVGLSGGGEEAGA | 51 | Q9Y663 | |
| SGPGVVRAGVLGAAG | 2086 | Q9UMN6 | |
| TGTGGEAVAAVVAGP | 6 | Q9HCN3 | |
| SGQVPVVAVLGSGGG | 351 | Q68DD2 | |
| ASGTVVAAAAGGPGP | 46 | P22059 | |
| IVQAAAGGVPGGGSN | 261 | Q9NR12 | |
| SGVGGPQQTVGEVGL | 661 | Q9NYA4 | |
| EPDGGLVVLSGGGTS | 96 | Q14397 | |
| QQGLAGPLGDSLGGD | 16 | Q0D2I5 | |
| AGPGGGGVSAGVAVL | 51 | Q96JP2 | |
| AIGAPFGGETQQGVV | 411 | P08648 | |
| SLEVGGEPLGTSGSG | 936 | O14559 | |
| VTGGCGGIFQAPSGE | 1506 | O60494 | |
| AIIDGTGSVGAALGP | 466 | P57057 | |
| LQGGPDDNLIEGGGT | 471 | Q96A65 | |
| GPVGAAGATGARGLV | 331 | P08123 | |
| AAGLVGGAGVVPGES | 281 | O43837 | |
| LIGGLGVTPSGNIGA | 266 | P50213 | |
| GTQASAVVGLGPPGE | 586 | P24394 | |
| TLGTELAEQQPGGGG | 371 | P22460 | |
| GLLETGAPVGDISGG | 356 | Q9Y6J0 | |
| AGGEPTVQLQGSGRG | 406 | Q8IVS8 | |
| EAGSTLPENLGGGSG | 196 | Q9ULE3 | |
| GTVEVGTGAGAGAEP | 251 | Q13520 | |
| GTGGLGLTVEGPCEA | 1096 | P21333 | |
| GAGLEGGVTGNPAEF | 2436 | P21333 | |
| GGAPSGSQGVLIGDR | 26 | Q96S94 | |
| GSGNLAVIGGVAVGV | 531 | P29317 | |
| GTGTGLEGGVCAVQG | 96 | Q86WU2 | |
| VPGIVGAVGQIGNTG | 581 | Q14055 | |
| LAGVGEGPPGTLQGT | 301 | Q96CU9 | |
| QNLLSGRVPGGTGEG | 121 | Q6NUI2 | |
| ILNGGGVPAGGLVAT | 81 | P09912 | |
| GGAAGPTQAGQSGVE | 531 | O75061 | |
| AGVPNGALRESGGSG | 666 | P00519 | |
| GQQRAVGPAGGGEAG | 321 | Q02410 | |
| GLSGGGGAPGELIVN | 716 | Q02246 | |
| SDGIGQGEGGPSVPL | 2261 | O15021 | |
| APVGRVGAAAVSGGG | 391 | Q9NU39 | |
| ALGALAGVGVGGPNI | 16 | P05106 | |
| GVLVTARTVPGGGFG | 486 | Q8N6U8 | |
| NGTLAGVVSGGAEPC | 211 | Q9UKQ9 | |
| GTVIGTGTGGLVEAG | 46 | Q96G42 | |
| TGTGGLVEAGGQPQP | 51 | Q96G42 | |
| VGSGSGSPDGAVVQG | 801 | Q13753 | |
| GKPGGTVESGNGEDL | 491 | Q9UK59 | |
| GVQGEQGATGLPGVQ | 736 | P20849 | |
| RGVDGQTGSGTVPGA | 866 | Q9BXX0 | |
| QTGSGTVPGAEGFAG | 871 | Q9BXX0 | |
| SPRGNALLVGVGGSG | 2816 | Q9NYC9 | |
| PGISSTGVGDGGNEL | 471 | Q7Z3D6 | |
| AAGAGVAQAGPLVDG | 121 | Q4V328 | |
| PGVGGLGVSAGAVVP | 116 | P15502 | |
| LGVSAGAVVPQPGAG | 121 | P15502 | |
| GIGGIAGVGTPAAAA | 291 | P15502 | |
| GTGGVPGVGTPAAAA | 476 | P15502 | |
| IPGGVVGAGPAAAAA | 676 | P15502 | |
| GVLGGAGQFPLGGVA | 746 | P15502 | |
| GGTALPEGGGAAQEN | 721 | Q9Y467 | |
| PREVGGQGAGNTGGL | 471 | Q7Z5L9 | |
| PGAHVVVTGGSSGIG | 31 | Q06136 | |
| GGSGSEIGVFSLGVP | 266 | Q9Y597 | |
| LSEPIDGGAGGNGLV | 11 | Q86T03 | |
| GTPGSQGLAGERGTV | 326 | Q96A83 | |
| QGLAGERGTVGPSGE | 331 | Q96A83 | |
| GEAGAVIGGSAGASP | 51 | Q07820 | |
| GGVSLRAGGGATAPL | 11 | Q8TB37 | |
| AAGVGAAGVVVGVGG | 121 | Q96G74 | |
| AAGVVVGVGGAVGVG | 126 | Q96G74 | |
| GQPGAGTILAGTSGL | 206 | Q96G25 | |
| AVGPARGGQGAEEVG | 66 | Q8TE04 | |
| GEGSVGGGLAVSPNP | 101 | Q8TBP5 | |
| DIDVVGGGSGGGELP | 26 | O60548 | |
| AVAVPLAGGQEGSPG | 16 | Q92541 | |
| GTSGGIGIAPGTVVI | 146 | O95045 | |
| SGVGVGAGLGAGVNQ | 141 | P48431 | |
| AGGGTGQVGQPAATA | 276 | Q02446 | |
| LEGGFSIGSVGPDGQ | 546 | Q13049 | |
| GLVGFGIGGVPQSVT | 181 | Q8N4V2 | |
| DVPGFAIGGLSGGES | 221 | Q9BXR0 | |
| ATVGGGTVIGVTGGL | 196 | Q5TGY1 | |
| GAQLGVVVSGAGAEG | 721 | Q24JP5 | |
| QQPGGTVVAGAVAGA | 101 | Q6PIV7 | |
| SAGNGTGAGTGAEVP | 31 | O75446 | |
| TGAGTGAEVPGAGAV | 36 | O75446 | |
| AAGAGVPGEATGRGA | 26 | O00358 | |
| VTQEPELASGGGGSG | 951 | Q7Z3K3 | |
| GTEAGQVGEPGIPTG | 221 | O15355 | |
| TGELGSGLQVGAPGA | 226 | Q9HAB3 | |
| GVLVPGGFGVRGTEG | 366 | P17812 | |
| GGGSEIGVFHLGVPV | 276 | Q8TBC3 | |
| NLGTGVVPAALGGAG | 431 | O15389 | |
| QGSIGGIVGDGRPVQ | 1661 | Q9HCD6 | |
| GGSGGGVPEQEDSVL | 6 | Q16637 | |
| SAGEAGPGGSQGRVV | 6 | Q5C9Z4 | |
| QGPGLGGRSGAEEAS | 106 | Q5C9Z4 | |
| VVPCVQGGGDGGGAS | 31 | B7ZBB8 | |
| LLESSGVIVGGGDNG | 81 | Q9NQW1 | |
| PAGSEGLGRAGVAVG | 36 | P57073 | |
| IELGVTGGGSPENGD | 2831 | Q6ZRS2 | |
| TGGGSPENGDGALLA | 2836 | Q6ZRS2 | |
| IDGGGGVGADAVNLT | 11 | P29371 | |
| QVLGGPVSGLSIGTG | 161 | P40967 | |
| GQGGGFEALGAPLDV | 586 | O94819 | |
| GSEGTAGLDVVPGGL | 636 | Q8IY92 | |
| VVVEGGSGEGQGSPS | 1126 | Q66K14 | |
| CVTSGEGQPTLGGTG | 286 | Q86T13 | |
| AQGFIGSPGEAGQLG | 616 | Q17RW2 | |
| LQGEPGAKGDVGTAG | 1021 | Q17RW2 | |
| VGTAGSVGGTGEPGL | 1031 | Q17RW2 | |
| NAVGGADSGPGVDRG | 461 | Q6UXD7 | |
| IENLPAEGSGGGGSL | 26 | Q5T1Q4 | |
| VPQGGVDACQGDSGG | 356 | O60235 | |
| VDPSTGLLIAAGGGG | 21 | Q9HCU5 | |
| GDGSGGSVVLPAGFA | 56 | P10074 | |
| GEKGAEATNVTGPGG | 151 | Q9Y2T7 | |
| GGDVETAGSGQAAGP | 101 | P98169 | |
| EEVAGRVGSSGGSGP | 236 | O15156 | |
| LVTGSAPGRDGGIAG | 1391 | O14924 | |
| GGGGGGTEVIQVTNV | 26 | Q05519 | |
| PKAVGNSGQLEGSGG | 231 | Q8TDD2 | |
| NGEAGGGPIGVLSTS | 686 | Q8TEJ3 | |
| GESGGGSLGAQPLLQ | 811 | P42226 | |
| VQTGDPTGTGRGGNS | 51 | Q9H2H8 | |
| LEQLGGTVTNPGGSG | 441 | Q15833 | |
| NGVVSLIGGPGSHIG | 646 | Q9UQD0 | |
| LDQGGGSLGPGAIAA | 81 | Q6UX34 | |
| TGEAGAGGGVEPSLE | 121 | Q71RG4 | |
| VQGGTTAIPGAFGCG | 241 | P38606 | |
| GVEGRDPVGGGNLTN | 46 | O75678 | |
| VVPGGGLEGGGVASQ | 916 | Q14151 | |
| NGGEPFLIGVSGGTA | 16 | Q9BZX2 | |
| VNESEGAAGGAGIPG | 56 | P36402 | |
| NGDRPSAGATVGGEG | 71 | Q8N1X5 | |
| AAAGAGVGGLSGPES | 991 | Q96JE7 | |
| TRTGGLGDPGQGTVA | 216 | Q8IUG5 | |
| RVNPSGLEGGTVEGG | 1906 | Q96JG9 | |
| GGGAAVPGAPAAVVV | 421 | P0CG23 | |
| VSGVQAGSPADGQGI | 406 | O95049 | |
| AGRGGNVGEGSESPL | 136 | Q6ZR54 | |
| GLFGVVPGGTETGDV | 76 | Q6ZMS4 | |
| VAGPGGLSGSTLVDG | 686 | Q9UPU5 | |
| GGGVVKVLGQGPGAA | 241 | O60346 | |
| TNAIGGPAAGVGGLT | 246 | Q96EQ0 | |
| FTPGVGVGVLGTAIG | 476 | Q9UHD9 | |
| GVSQGQEEGGGPLGH | 546 | Q9Y334 | |
| SVGISLGQGAEPGPG | 66 | Q9H091 | |
| GGGGAPGGLQHETQE | 46 | Q00577 | |
| QGGGATPVVGAVQGP | 126 | P09012 | |
| QAGELGPGTIVGSAA | 156 | Q9UPR5 | |
| QPAGGVAAAGGVVSG | 241 | Q96RE7 | |
| LPTVGGQLGTAGQGF | 91 | Q9NP98 |